Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

BACKGROUND:<br>Familial hypercholesterolaemia (FH) is an inherited lipid disorder causing premature heart disease, which is severely underdiagnosed. Improving the identification of people with FH in primary care settings would help to reduce avoidable heart attacks and early deaths. AIM:To eva...

Полное описание

Библиографические подробности
Главные авторы:	Akyea, RK, Qureshi, N, Kai, J, de Lusignan, S, Sherlock, J, McGee, C, Weng, S
Формат:	Journal article
Язык:	English
Опубликовано:	Royal College of General Practitioners 2020

Схожие документы

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study
по: Ralph K Akyea, и др.
Опубликовано: (2020-11-01)

Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care
по: Stephen Weng, PhD, и др.
Опубликовано: (2019-05-01)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
по: Joe Kai, и др.
Опубликовано: (2021-12-01)

Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
по: Ralph K. Akyea, и др.
Опубликовано: (2020-10-01)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
по: Joe Kai, и др.
Опубликовано: (2021-12-01)

Familial hypercholesterolaemia
по: D.J. Blom
Опубликовано: (2011-01-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
по: Minhas, R, и др.
Опубликовано: (2009)

Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study
по: Anis Safura Ramli, и др.
Опубликовано: (2023-06-01)

Familial hypercholesterolaemia.
по: Gill, P, и др.
Опубликовано: (2012)

Statins and familial hypercholesterolaemia.
по: Neil, A, и др.
Опубликовано: (2009)

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
по: Nadeem Qureshi, и др.
Опубликовано: (2023-10-01)

EASILY MISSED? Familial hypercholesterolaemia
по: Gill, P, и др.
Опубликовано: (2012)

Familial Hypercholesterolaemia: An Updated Overall Management
по: Mohd Kasim, Noor Alicezah, и др.
Опубликовано: (2020)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
по: Vallejo-Vaz, Antonio J., и др.
Опубликовано: (2020)

Familial Hypercholesterolaemia – a targeted Next Generation Sequencing panel and retrospective analysis of patients with no previously identified pathogenic variant
по: E. Willis, и др.
Опубликовано: (2022-10-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
по: Marks, D, и др.
Опубликовано: (2000)

Novel molecular therapies for the treatment of familial hypercholesterolaemia
по: Kerr, A
Опубликовано: (2016)

International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
по: Gerald F. Watts, и др.
Опубликовано: (2024-01-01)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
по: Anastasia V. Poznyak, и др.
Опубликовано: (2022-10-01)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
по: Maria Elena Capra, и др.
Опубликовано: (2023-06-01)

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
по: J. Cegla, и др.
Опубликовано: (2023-12-01)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
по: Humphries, SE, и др.
Опубликовано: (2005)

A perspective for sequencing familial hypercholesterolaemia in African Americans
по: Wright, Michelle L, и др.
Опубликовано: (2018)

Commentary: What's so special about familial hypercholesterolaemia?
по: Mant, D
Опубликовано: (2009)

Recent advances in the management and implementation of care for familial hypercholesterolaemia
по: Nick S.R. Lan, и др.
Опубликовано: (2023-08-01)

Hypercholesterolaemia treatment in a patient with family hypercholesterolaemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors
по: P. Luque Linero, и др.
Опубликовано: (2022-04-01)

Assessment of GENinCode in the Diagnosis of Patients with Suspected Familial Hypercholesterolaemia
по: P.E. Carey, и др.
Опубликовано: (2022-10-01)

An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
по: J. Webster, и др.
Опубликовано: (2022-10-01)

Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study
по: Merete Heitmann, и др.
Опубликовано: (2024-02-01)

Inclisiran for the treatment of hypercholesterolaemia
по: Joel C Marrs, и др.
Опубликовано: (2024-11-01)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
по: S.E. Humphries, и др.
Опубликовано: (2023-12-01)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
по: Marks, D, и др.
Опубликовано: (2003)

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
по: Marks, D, и др.
Опубликовано: (2002)

Triple-combined hypolipidaemic therapy in familial hypercholesterolaemia: clinical cases
по: Svetlana A. Chepurnenko, и др.
Опубликовано: (2021-10-01)

Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia
по: E. Ofagbor, и др.
Опубликовано: (2023-12-01)

Genetics in familial hypercholesterolaemia – from genetic research to new guidelines
по: Edyta Kinga Prokop, и др.
Опубликовано: (2019-04-01)

Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
по: Alexander R.M. Lyons, и др.
Опубликовано: (2024-03-01)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
по: Neil, A, и др.
Опубликовано: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
по: Neil, H, и др.
Опубликовано: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
по: Neil, H, и др.
Опубликовано: (2004)